Old information. It was initially planned as an investigator-initiated trial. In that text, there is a link to this previous clinical trials page ClinicalTrials.gov. That study was initially planned under the name Bexlung, but now I suppose Blaze replaces that and Gilead’s molecule acts as the PD-1 inhibitor.
7 Likes